Abstract
Caenorhabditis elegans (C. elegans) allows exhaustive analysis of animal biology, in detail once thought possible only for microbial organisms. This detail includes the entire cellular lineage from egg to adult, the complete adult cell complement, a full wiring diagram of the nervous system, and several hundred gene mutants that produce classical phenotypes. With the rise of genomic sequencing and functional genomics, analysis of C. elegans has grown to include reverse genetics, microarray assays of gene expression, and protein-protein interactions. Such studies should soon touch upon all ∼19,400 predicted C. elegans proteins and their detailed expression patterns. This should illuminate, but also complicate, our understanding of C. elegans cells and genetic pathways. Moreover, the newer forms of analysis are explicitly directed at acquiring data that are highly valuable with computational analysis but unintelligible without it. We describe the existing data sets and databases for C. elegans, and discuss ways in which large C. elegans data sets may be integrated.
Keywords: Caenorhabditis elegans, genomics
Current Genomics
Title: Caenorhabditis elegans Databases
Volume: 3 Issue: 2
Author(s): E. M. Schwarz, L. D. Stein and P. W. Sternberg
Affiliation:
Keywords: Caenorhabditis elegans, genomics
Abstract: Caenorhabditis elegans (C. elegans) allows exhaustive analysis of animal biology, in detail once thought possible only for microbial organisms. This detail includes the entire cellular lineage from egg to adult, the complete adult cell complement, a full wiring diagram of the nervous system, and several hundred gene mutants that produce classical phenotypes. With the rise of genomic sequencing and functional genomics, analysis of C. elegans has grown to include reverse genetics, microarray assays of gene expression, and protein-protein interactions. Such studies should soon touch upon all ∼19,400 predicted C. elegans proteins and their detailed expression patterns. This should illuminate, but also complicate, our understanding of C. elegans cells and genetic pathways. Moreover, the newer forms of analysis are explicitly directed at acquiring data that are highly valuable with computational analysis but unintelligible without it. We describe the existing data sets and databases for C. elegans, and discuss ways in which large C. elegans data sets may be integrated.
Export Options
About this article
Cite this article as:
Schwarz M. E., Stein D. L. and Sternberg W. P., Caenorhabditis elegans Databases, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605189
DOI https://dx.doi.org/10.2174/1389202024605189 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Induction of Cytochrome P450 3A4 and P-Glycoprotein by the Isoxazolyl- Penicillin Antibiotic Flucloxacillin
Current Drug Metabolism Aryl and Acyclic Unsaturated Derivatives of Thioguanine and 6- Mercaptopurine: Synthesis and Cytotoxic Activity
Letters in Drug Design & Discovery Recent Developments in the Search for Biomarkers for the Diagnosis and Monitoring of Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Production of Copper Radionuclides in Compact Medical Cyclotrons using Solid Targets
Current Radiopharmaceuticals Synthesis, Evaluation and Molecular Docking Studies of 1,3,4-oxadiazole- 2-thiol Incorporating Fatty Acid Moiety as Antitumor and Antimicrobial Agents
Letters in Drug Design & Discovery Inhibition of Alkaline Phosphatase: An Emerging New Drug Target
Mini-Reviews in Medicinal Chemistry Probing the Leucyl/Phenylalanyl tRNA Protein Transferase Active Site with tRNA Substrate Analogues
Protein & Peptide Letters GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma
Current Drug Targets Lemon Juice: A Versatile Reusable Biocatalyst for the Synthesis of Bioactive Organic Compounds as well as Numerous Nanoparticles Based Catalytic System
Current Organic Chemistry Synthesis of 2-(Bis (2-Chloroethyl)Amino)-N-(5-Substitutedphenyl)- 1,3,4- Thiadiazol-2-Yl)Acetohydrazide And Evaluation of Anticancer Activity
Current Bioactive Compounds Evaluation of Synthetic Cell-Penetrating Peptides, Pro-Rich Peptide and Octaargine Derivatives, as Adenovirus Vector Carrier
Protein & Peptide Letters Preface
Letters in Drug Design & Discovery Voltage-Gated Sodium Channel Blockers for the Treatment of Chronic Pain
Current Topics in Medicinal Chemistry Use of the Semiconductor Nanotechnologies “Quantum Dots” for in vivo Cancer Imaging
Recent Patents on Anti-Cancer Drug Discovery Multiscale Products in B-spline Wavelet Domain: A New Method for Short Exon Detection
Current Bioinformatics Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells
Medicinal Chemistry Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy
Current Pharmaceutical Design Controlled Exploration of Structural Databases: The Case of Farnesyl Transferase Inhibitors
Medicinal Chemistry Microemulsions for Colorectal Cancer Treatments. General Considerations and Formulation of Methotrexate
Mini-Reviews in Medicinal Chemistry Seeing the Light: Luminescent Reporter Gene Assays
Combinatorial Chemistry & High Throughput Screening